1. Home
  2. GILT vs AVIR Comparison

GILT vs AVIR Comparison

Compare GILT & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gilat Satellite Networks Ltd.

GILT

Gilat Satellite Networks Ltd.

HOLD

Current Price

$11.39

Market Cap

747.5M

Sector

Technology

ML Signal

HOLD

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$3.12

Market Cap

236.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GILT
AVIR
Founded
1987
2012
Country
Israel
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
747.5M
236.7M
IPO Year
1993
2020

Fundamental Metrics

Financial Performance
Metric
GILT
AVIR
Price
$11.39
$3.12
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$16.00
$6.00
AVG Volume (30 Days)
497.8K
350.0K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
42.22
N/A
EPS
0.41
N/A
Revenue
$392,826,000.00
N/A
Revenue This Year
$49.48
N/A
Revenue Next Year
$13.61
N/A
P/E Ratio
$27.45
N/A
Revenue Growth
29.68
N/A
52 Week Low
$5.30
$2.46
52 Week High
$15.24
$4.02

Technical Indicators

Market Signals
Indicator
GILT
AVIR
Relative Strength Index (RSI) 41.95 49.92
Support Level $11.28 $3.11
Resistance Level $13.08 $3.27
Average True Range (ATR) 0.49 0.10
MACD -0.00 0.01
Stochastic Oscillator 8.64 54.41

Price Performance

Historical Comparison
GILT
AVIR

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Share on Social Networks: